Publications and Digital Products

This Advisory is based on TIP 39, Substance Use Disorder Treatment and Family Therapy. It surveys basic factors for programs and providers to consider when implementing family-related therapy approaches, goals and processes for conducting effective family counseling, and resources for further learning about family therapy techniques and models.

This advisory discusses the interaction between obsessive-compulsive disorder (OCD) and substance use disorder. It provides clinicians with an overview of screening and evidence-based treatments for OCD.

This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

This advisory equips substance use treatment and service providers with information about eating disorders and their relationship to substance use disorders. It provides an overview of screening, referrals, and evidence-based treatments for eating disorders and lists resources for more information.

This advisory gives substance use treatment and service providers updated facts about OxyContin. It describes its use and misuse, addiction and dependency, withdrawal symptoms, and treatment and detoxification protocols, including medication-assisted treatment.